Oncology Research2026，Vol.34Issue(7)：P.651-665,15.DOI:10.32604/or.2026.079813
Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer
Zhen Wang 1Qian Xie 2Yu Luo 3Chuan Li 1Wenqiang Guan 1Yanling Zhang 4Jidong Miao1
作者信息
- 1. Department of Oncology,Zigong Fourth People’s Hospital,Ziliujing District,Zigong,China
- 2. School of Education and Sports,Sichuan Vocational College of Health and Rehabilitation,Yantian District,Zigong,China
- 3. Department of Critical Care,Qingdao Municipal Hospital,Shinan District,Qingdao,China
- 4. Department of Respiratory and Critical Care Medicine,Qingdao Municipal Hospital,Qingdao University,Shinan District,Qingdao,China
- 折叠
摘要
关键词
Advanced non-small cell lung cancer/PD-1 inhibitors/safety/immune-related adverse events/prognosis分类
医药卫生引用本文复制引用
Zhen Wang,Qian Xie,Yu Luo,Chuan Li,Wenqiang Guan,Yanling Zhang,Jidong Miao..Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer[J].Oncology Research,2026,34(7):P.651-665,15.
